Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Moderna reported third-quarter financial results on Thursday. The transcript from the company's earnings call has been prov...
Moderna (NASDAQ:MRNA) narrows FY2025 sales outlook from $1.500 billion-$2.200 billion to $1.600 billion-$2.000 billion vs $1.89...
Moderna (NASDAQ:MRNA) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(2.02) by 74...
Moderna stock is trading sharply lower Monday afternoon as recent clinical setbacks overshadowed positive pipeline news.
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Fr...
